← Evidence map

ArticleFrontiers in immunology2024

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study.

Na Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39676868